Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (235)	12/3/1997 1:28:00 PM
From: 5,17,37,5,101,...	Read Replies (1) \| Respond to of 756

According to FDA Talk Papers (4?/97), the FDA says that "no time soon" will it require CFC-Free metered dose inhalers. It noted the MMM-Schering CFC-Free inhaler Proventil (spell?) is already on the market. This inhaler news is difficult to digest because the information is scant and dispersed and cash flows appear relatively far into the future and uncertain. The market didn't much care for the news though since IVX is still down about 3.3% since. The clozapine news is better I think. The market apparently liked the news, I guess, since IVX is up about 3% since. I appreciate your observation that Novartis felt compelled to respond. Jackson